To be or not to be: The host genetic factor and beyond in Helicobacter pylori mediated gastro-duodenal diseases

World Journal of Gastroenterology

Volumn 21, Issue 10, 2015, Pages 2883-2895

  Datta De, Dipanjana ^a   Roychoudhury, Susanta ^b  

^a School of Human Genetics and Population Health   (India)

^b INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

Acid secretion; Cytokine; Duodenal ulcer; Gastric cancer; Helicobacter pylori

Indexed keywords

BONE MORPHOGENETIC PROTEIN; CAGA PROTEIN; GASTRIN; INTERLEUKIN 1BETA; MYELOID DIFFERENTIATION FACTOR 88; SOMATOSTATIN; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; VIRULENCE FACTOR; IL1B PROTEIN, HUMAN;

BACTERIAL VIRULENCE; DUODENUM DISEASE; DUODENUM ULCER; ENTEROCHROMAFFIN LIKE CELL; GENETIC HETEROGENEITY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEREDITY; HOST PATHOGEN INTERACTION; NONHUMAN; PROTEIN EXPRESSION; REVIEW; STOMACH ACID SECRETION; STOMACH CANCER; STOMACH DISEASE; STOMACH ULCER; ANIMAL; CELL TRANSFORMATION; COMPLICATION; GASTRIC MUCOSA; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HUMAN; METABOLISM; MICROBIOLOGY; MOLECULAR MIMICRY; PATHOGENICITY; PHENOTYPE; RISK FACTOR; SECRETION (PROCESS); SIGNAL TRANSDUCTION; STOMACH ACID; STOMACH TUMOR; VIRULENCE;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; DUODENAL ULCER; GASTRIC ACID; GASTRIC MUCOSA; GASTRINS; GENETIC PREDISPOSITION TO DISEASE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERLEUKIN-1BETA; MOLECULAR MIMICRY; PHENOTYPE; POLYMORPHISM, GENETIC; RISK FACTORS; SIGNAL TRANSDUCTION; SOMATOSTATIN; STOMACH NEOPLASMS; VIRULENCE;

EID: 84925004355     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i10.2883     Document Type: Review

References (84)

1. Atherton JC, Cao P, Peek RM, Tummuru MK, Blaser MJ, Cover TL. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 1995; 270: 17771-17777 [PMID: 7629077]
2. Blaser MJ, Atherton JC. Helicobacter pylori persistence: biology and disease. J Clin Invest 2004; 113: 321-333 [PMID: 14755326 DOI: 10.1172/JCI20925]
3. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002; 347: 1175-1186 [PMID: 12374879 DOI: 10.1056/NEJMra020542]
4. Dixon M. Pathology of Gastritis and Peptic Ulceration. In: Mobley HLT, Mendz GL, and Hazell SL, editors. Helicobacter pylori: Physiology and Genetics. Washington, DC: ASM press, 2001: 459-469
5. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-789 [PMID: 11556297 DOI: 10.1056/NEJMoa001999]
6. Ilver D, Arnqvist A, Ogren J, Frick IM, Kersulyte D, Incecik ET, Berg DE, Covacci A, Engstrand L, Borén T. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 1998; 279: 373-377 [PMID: 9430586]
7. Mahdavi J, Sondén B, Hurtig M, Olfat FO, Forsberg L, Roche N, Angstrom J, Larsson T, Teneberg S, Karlsson KA, Altraja S, Wadström T, Kersulyte D, Berg DE, Dubois A, Petersson C, Magnusson KE, Norberg T, Lindh F, Lundskog BB, Arnqvist A, Hammarström L, Borén T. Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science 2002; 297: 573-578 [PMID: 12142529]
8. Pütsep K, Brändén CI, Boman HG, Normark S. Antibacterial peptide from H. pylori. Nature 1999; 398: 671-672 [PMID: 10227288 DOI: 10.1038/19439]
9. Guillemin K, Salama NR, Tompkins LS, Falkow S. Cag pathogenicity island-specific responses of gastric epithelial cells to Helicobacter pylori infection. Proc Natl Acad Sci USA 2002; 99: 15136-15141 [PMID: 12411577 DOI: 10.1073/pnas.182558799]
10. Odenbreit S, Püls J, Sedlmaier B, Gerland E, Fischer W, Haas R. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 2000; 287: 1497-1500 [PMID: 10688800]
11. Cover TL, Cao P, Lind CD, Tham KT, Blaser MJ. Correlation between vacuolating cytotoxin production by Helicobacter pylori isolates in vitro and in vivo. Infect Immun 1993; 61: 5008-5012 [PMID: 8225576]
12. Perez-Perez GI, Dworkin BM, Chodos JE, Blaser MJ. Campylobacter pylori antibodies in humans. Ann Intern Med 1988; 109: 11-17 [PMID: 3288028 DOI: 10.7326/0003-4819-109-1-11]
13. Dooley CP, Cohen H, Fitzgibbons PL, Bauer M, Appleman MD, Perez-Perez GI, Blaser MJ. Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med 1989; 321: 1562-1566 [PMID: 2586553 DOI: 10.1056/NEJM198912073212302]
14. Baldwin DN, Shepherd B, Kraemer P, Hall MK, Sycuro LK, Pinto-Santini DM, Salama NR. Identification of Helicobacter pylori genes that contribute to stomach colonization. Infect Immun 2007; 75: 1005-1016 [PMID: 17101654 DOI: 10.1128/IAI.01176-06]
15. Guo BP, Mekalanos JJ. Rapid genetic analysis of Helicobacter pylori gastric mucosal colonization in suckling mice. Proc Natl Acad Sci USA 2002; 99: 8354-8359 [PMID: 12060779 DOI: 10.1073/pnas.122244899]
16. Kavermann H, Burns BP, Angermuller K, Odenbreit S, Fischer W, Melchers K, Haas R. Identification and characterization of Helicobacter pylori genes essential for gastric colonization. J Exp Med 2003; 197: 813-822 [PMID: 12668646 DOI: 10.1084/jem.20021531]
17. Castillo AR, Woodruff AJ, Connolly LE, Sause WE, Ottemann KM. Recombination-based in vivo expression technology identifies Helicobacter pylori genes important for host colonization. Infect Immun 2008; 76: 5632-5644 [PMID: 18794279 DOI: 10.1128/IAI.00627-08]
18. Yamaoka Y. Mechanisms of disease: Helicobacter pylori virulence factors. Nat Rev Gastroenterol Hepatol 2010; 7: 629-641 [PMID: 20938460]
19. Suerbaum S, Josenhans C. Helicobacter pylori evolution and phenotypic diversification in a changing host. Nat Rev Microbiol 2007; 5: 441-452 [PMID: 17505524]
20. Cao P, Cover TL. Two different families of hopQ alleles in Helicobacter pylori. J Clin Microbiol 2002; 40: 4504-4511 [PMID: 12454143 DOI: 10.1128/JCM.40.12.4504-4511.2002]
21. Ogura M, Perez JC, Mittl PR, Lee HK, Dailide G, Tan S, Ito Y, Secka O, Dailidiene D, Putty K, Berg DE, Kalia A. Helicobacter pylori evolution: lineage- specific adaptations in homologs of eukaryotic Sel1-like genes. PLoS Comput Biol 2007; 3: e151 [PMID: 17696605 DOI: 10.1371/journal.pcbi.0030151]
22. Gerhard M, Lehn N, Neumayer N, Borén T, Rad R, Schepp W, Miehlke S, Classen M, Prinz C. Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc Natl Acad Sci USA 1999; 96: 12778-12783 [PMID: 10535999 DOI: 10.1073/pnas.96.22.12778]
23. Van Doorn LJ, Figueiredo C, Mégraud F, Pena S, Midolo P, Queiroz DM, Carneiro F, Vanderborght B, Pegado MD, Sanna R, De Boer W, Schneeberger PM, Correa P, Ng EK, Atherton J, Blaser MJ, Quint WG. Geographic distribution of vacA allelic types of Helicobacter pylori. Gastroenterology 1999; 116: 823-830 [PMID: 10092304 DOI: 10.1016/S0016-5085(99)70065-X]
24. Atherton JC, Tham KT, Peek RM, Cover TL, Blaser MJ. Density of Helicobacter pylori infection in vivo as assessed by quantitative culture and histology. J Infect Dis 1996; 174: 552-556 [PMID: 8769613 DOI: 10.1093/infdis/174.3.552]
25. Lu H, Hsu PI, Graham DY, Yamaoka Y. Duodenal ulcer promoting gene of Helicobacter pylori. Gastroenterology 2005; 128: 833-848 [PMID: 15825067 DOI: 10.1053/j.gastro.2005.01.009]
26. Go MF. Review article: natural history and epidemiology of Helicobacter pylori infection. Aliment Pharmacol Ther 2002; 16 Suppl 1: 3-15 [PMID: 11849122 DOI: 10.1046/j.1365-2036.2002.0160s1003.x]
27. El-Omar EM, Oien K, El-Nujumi A, Gillen D, Wirz A, Dahill S, Williams C, Ardill JE, McColl KE. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 1997; 113: 15-24 [PMID: 9207257 DOI: 10.1016/S0016-5085(97)70075-1]
28. di Giovine FS, Takhsh E, Blakemore AI, Duff GW. Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta). Hum Mol Genet 1992; 1: 450 [PMID: 1301918 DOI: 10.1093/hmg/1.6.450]
29. Stokkers PC, van Aken BE, Basoski N, Reitsma PH, Tytgat GN, van Deventer SJ. Five genetic markers in the interleukin 1 family in relation to inflammatory bowel disease. Gut 1998; 43: 33-39 [PMID: 9771403 DOI: 10.1136/gut.43.1.33]
30. Hwang IR, Kodama T, Kikuchi S, Sakai K, Peterson LE, Graham DY, Yamaoka Y. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology 2002; 123: 1793-1803 [PMID: 12454835 DOI: 10.1053/gast.2002.37043]
31. Chen H, Wilkins LM, Aziz N, Cannings C, Wyllie DH, Bingle C, Rogus J, Beck JD, Offenbacher S, Cork MJ, Rafie-Kolpin M, Hsieh CM, Kornman KS, Duff GW. Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum Mol Genet 2006; 15: 519-529 [PMID: 16399797 DOI: 10.1093/hmg/ddi469]
32. Duff GW. Genetic variation in cytokines and relevance to inflammation and disease. In: Balkwill F, editor. The Cytokine Network Frontiers in Molecular Biology. Oxford: Oxford University Press, 2000: 152
33. Robert A, Olafsson AS, Lancaster C, Zhang WR. Interleukin-1 is cytoprotective, antisecretory, stimulates PGE2 synthesis by the stomach, and retards gastric emptying. Life Sci 1991; 48: 123-134 [PMID: 1825231 DOI: 10.1016/0024-3205(91)90405-Z]
34. El-Omar EM, Rabkin CS, Gammon MD, Vaughan TL, Risch HA, Schoenberg JB, Stanford JL, Mayne ST, Goedert J, Blot WJ, Fraumeni JF, Chow WH. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2003; 124: 1193-1201 [PMID: 12730860 DOI: 10.1016/S0016-5085(03)00157-4]
35. Machado JC, Pharoah P, Sousa S, Carvalho R, Oliveira C, Figueiredo C, Amorim A, Seruca R, Caldas C, Carneiro F, Sobrinho-Simões M. Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 2001; 121: 823-829 [PMID: 11606496 DOI: 10.1053/gast.2001.28000]
36. Furuta T, Shirai N, Takashima M, Xiao F, Sugimura H. Effect of genotypic differences in interleukin-1 beta on gastric acid secretion in Japanese patients infected with Helicobacter pylori. Am J Med 2002; 112: 141-143 [PMID: 11835953 DOI: 10.1016/S0002-9343(01)01036-1]
37. Garza-González E, Hold G, Pérez-Pérez GI, Bosques-Padilla FJ, Tijerina-Menchaca R, Maldonado-Garza HJ, el-Omar E. [Role of polymorphism of certain cytokines in gastric cancer in Mexico. Preliminary results]. Rev Gastroenterol Mex 2003; 68: 107-112 [PMID: 15127646]
38. Chakravorty M, Ghosh A, Choudhury A, Santra A, Hembrum J, Roychoudhury S. Interaction between IL1B gene promoter polymorphisms in determining susceptibility to Helicobacter pylori associated duodenal ulcer. Hum Mutat 2006; 27: 411-419 [PMID: 16550552 DOI: 10.1002/humu.20299]
39. García-González MA, Lanas A, Savelkoul PH, Santolaria S, Benito R, Crusius JB, Peña AS. Association of interleukin 1 gene family polymorphisms with duodenal ulcer disease. Clin Exp Immunol 2003; 134: 525-531 [PMID: 14632761 DOI: 10.1111/j.1365-2249.2003.02325.x]
40. Lee SG, Kim B, Choi W, Lee I, Choi J, Song K. Lack of association between pro-inflammatory genotypes of the interleukin-1 (IL-1B -31 C/+ and IL-1RN∗2/∗2) and gastric cancer/duodenal ulcer in Korean population. Cytokine 2003; 21: 167-171 [PMID: 12788304 DOI: 10.1016/S1043-4666(03)00032-2]
41. Kato S, Onda M, Yamada S, Matsuda N, Tokunaga A, Matsukura N. Association of the interleukin-1 beta genetic polymorphism and gastric cancer risk in Japanese. J Gastroenterol 2001; 36: 696-699 [PMID: 11686480 DOI: 10.1007/s005350170033]
42. He X, Jiang L, Fu B, Zhang X. [Relationship between interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms and susceptibility to gastric cancer]. Zhonghua Yi Xue Zazhi 2002; 82: 685-688 [PMID: 12133467]
43. Takagi A, Deguchi R, Kobayashi K, Miwa T. Cytokine expressions and H. pylori-associated gastric mucosal lesion. Keio J Med 2002; 51 Suppl 2: 51-52 [PMID: 12528938 DOI: 10.2302/kjm.51.supplement2-51]
44. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, Fraumeni JF, Rabkin CS. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404: 398-402 [PMID: 10746728 DOI: 10.1038/35006081]
45. El-Omar EM, Oien K, Murray LS, El-Nujumi A, Wirz A, Gillen D, Williams C, Fullarton G, McColl KE. Increased prevalence of precancerous changes in relatives of gastric cancer patients: critical role of H. pylori. Gastroenterology 2000; 118: 22-30 [PMID: 10611150 DOI: 10.1016/S0016-5085(00)70410-0]
46. Zhang BB, Wang J, Bian DL, Chen XY. No association between IL-1β -31 C/T polymorphism and the risk of duodenal ulcer: a meta-analysis of 3793 subjects. Hum Immunol 2012; 73: 1200-1206 [PMID: 22917539 DOI: 10.1016/j.humimm.2012.08.006]
47. Kunstmann E, Epplen C, Elitok E, Harder M, Suerbaum S, Peitz U, Schmiegel W, Epplen JT. Helicobacter pylori infection and polymorphisms in the tumor necrosis factor region. Electrophoresis 1999; 20: 1756-1761 [PMID: 10435444]
48. Jang WH, Yang YI, Yea SS, Lee YJ, Chun JH, Kim HI, Kim MS, Paik KH. The -238 tumor necrosis factor-alpha promoter polymorphism is associated with decreased susceptibility to cancers. Cancer Lett 2001; 166: 41-46 [PMID: 11295285 DOI: 10.1016/S0304-3835(01)00438-4]
49. Zambon CF, Basso D, Navaglia F, Belluco C, Falda A, Fogar P, Greco E, Gallo N, Rugge M, Di Mario F, Plebani M. Pro- and antiinflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome. Cytokine 2005; 29: 141-152 [PMID: 15652446 DOI: 10.1016/j.cyto.2004.10.013]
50. Lobo Gatti L, Zambaldi Tunes M, de Lábio RW, Silva LC, de Arruda Cardoso Smith M, Marques Payão SL. Interleukin-6 polymorphism and Helicobacter pylori infection in Brazilian adult patients with chronic gastritis. Clin Exp Med 2005; 5: 112-116 [PMID: 16284733 DOI: 10.1007/s10238-005-0074-3]
51. Savage SA, Abnet CC, Mark SD, Qiao YL, Dong ZW, Dawsey SM, Taylor PR, Chanock SJ. Variants of the IL8 and IL8RB genes and risk for gastric cardia adenocarcinoma and esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2004; 13: 2251-2257 [PMID: 15598788]
52. Kato I, van Doorn LJ, Canzian F, Plummer M, Franceschi S, Vivas J, Lopez G, Lu Y, Gioia-Patricola L, Severson RK, Schwartz AG, Muñoz N. Host-bacterial interaction in the development of gastric precancerous lesions in a high risk population for gastric cancer in Venezuela. Int J Cancer 2006; 119: 1666-1671 [PMID: 16671087 DOI: 10.1002/ijc.21979]
53. International HapMap Consortium. The International HapMap Project. Nature 2003; 426: 789-796 [PMID: 14685227 DOI: 10.1038/nature02168]
54. Indian Genome Variation Consortium. The Indian Genome Variation database (IGVdb): a project overview. Hum Genet 2005; 118: 1-11 [PMID: 16133172 DOI: 10.1007/s00439-005-0009-9]
55. Viala J, Chaput C, Boneca IG, Cardona A, Girardin SE, Moran AP, Athman R, Mémet S, Huerre MR, Coyle AJ, DiStefano PS, Sansonetti PJ, Labigne A, Bertin J, Philpott DJ, Ferrero RL. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol 2004; 5: 1166-1174 [PMID: 15489856 DOI: 10.1038/ni1131]
56. Hold GL, Rabkin CS, Gammon MD, Berry SH, Smith MG, Lissowska J, Risch HA, Chow WH, Mowat NA, Vaughan TL, El-Omar EM. CD14-159C/T and TLR9-1237T/C polymorphisms are not associated with gastric cancer risk in Caucasian populations. Eur J Cancer Prev 2009; 18: 117-119 [PMID: 19337058 DOI: 10.1097/CEJ.0b013e3283101292]
57. Lamb A, Yang XD, Tsang YH, Li JD, Higashi H, Hatakeyama M, Peek RM, Blanke SR, Chen LF. Helicobacter pylori CagA activates NF-kappaB by targeting TAK1 for TRAF6-mediated Lys 63 ubiquitination. EMBO Rep 2009; 10: 1242-1249 [PMID: 19820695 DOI: 10.1038/embor.2009.210]
58. Maeda S, Yoshida H, Ogura K, Mitsuno Y, Hirata Y, Yamaji Y, Akanuma M, Shiratori Y, Omata M. H. pylori activates NF-kappaB through a signaling pathway involving IkappaB kinases, NF-kappaB-inducing kinase, TRAF2, and TRAF6 in gastric cancer cells. Gastroenterology 2000; 119: 97-108 [PMID: 10889159 DOI: 10.1053/gast.2000.8540]
59. Saitoh T, Kirikoshi H, Mine T, Katoh M. Proto-oncogene WNT10B is up-regulated by tumor necrosis factor alpha in human gastric cancer cell line MKN45. Int J Oncol 2001; 19: 1187-1192 [PMID: 11713588]
60. Bleuming SA, Kodach LL, Garcia Leon MJ, Richel DJ, Peppelenbosch MP, Reitsma PH, Hardwick JC, van den Brink GR. Altered bone morphogenetic protein signalling in the Helicobacter pylori-infected stomach. J Pathol 2006; 209: 190-197 [PMID: 16550632 DOI: 10.1002/path.1976]
61. Mayerle J, den Hoed CM, Schurmann C, Stolk L, Homuth G, Peters MJ, Capelle LG, Zimmermann K, Rivadeneira F, Gruska S, Völzke H, de Vries AC, Völker U, Teumer A, van Meurs JB, Steinmetz I, Nauck M, Ernst F, Weiss FU, Hofman A, Zenker M, Kroemer HK, Prokisch H, Uitterlinden AG, Lerch MM, Kuipers EJ. Identification of genetic loci associated with Helicobacter pylori serologic status. JAMA 2013; 309: 1912-1920 [PMID: 23652523 DOI: 10.1001/jama.2013.4350]
62. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M, Frees K, Watt JL, Schwartz DA. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000; 25: 187-191 [PMID: 10835634 DOI: 10.1038/76048]
63. El-Omar EM, Ng MT, Hold GL. Polymorphisms in Toll-like receptor genes and risk of cancer. Oncogene 2008; 27: 244-252 [PMID: 18176606 DOI: 10.1038/sj.onc.1210912]
64. Katoh Y, Katoh M. Hedgehog signaling pathway and gastrointestinal stem cell signaling network (review). Int J Mol Med 2006; 18: 1019-1023 [PMID: 17089004]
65. Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, Taite H, Scoular R, Miller A, Reeve AE. E-cadherin germline mutations in familial gastric cancer. Nature 1998; 392: 402-405 [PMID: 9537325 DOI: 10.1038/32918]
66. Meyer-Rosberg K, Scott DR, Rex D, Melchers K, Sachs G. The effect of environmental pH on the proton motive force of Helicobacter pylori. Gastroenterology 1996; 111: 886-900 [PMID: 8831583 DOI: 10.1016/S0016-5085(96)70056-2]
67. Cave DR, King WW, Hoffman JS. Production of two chemically distinct acid inhibitory factors by Helicobacter pylori. Eur J Gastroenterol Hepatol 1993; 5: S23-S27
68. Konturek PC, Brzozowski T, Karczewska E, Duda A, Bielański W, Hahn EG, Konturek SJ. Water extracts of Helicobacter pylori suppress the expression of histidine decarboxylase and reduce histamine content in the rat gastric mucosa. Digestion 2000; 62: 100-109 [PMID: 11025357 DOI: 10.1159/000007802]
69. Zaki M, Coudron PE, McCuen R. Helicobacter pylori, acting via neural pathways, stimulates somatostatin and thus inhibits histamine and acid secretion in the fundus of rat stomach. Gastroenterology 1998; 114: A344 [DOI: 10.1016/S0016-5085(98)81394-2]
70. Beales IL, Calam J. Inhibition of carbachol stimulated acid secretion by interleukin 1beta in rabbit parietal cells requires protein kinase C. Gut 2001; 48: 782-789 [PMID: 11358895 DOI: 10.1136/gut.48.6.782]
71. El-Omar EM. Mechanisms of increased acid secretion after eradication of Helicobacter pylori infection. Gut 2006; 55: 144-146 [PMID: 16407378 DOI: 10.1136/gut.2005.071779]
72. Kato S, Matsukura N, Matsuda N, Tsukada K, Naito Z, Tajiri T. Helicobacter pylori eradication therapy modulates acidity and interleukin-1β mRNA levels in un-operated stomach and in remnant stomach after gastrectomy in gastric cancer patients. Aliment Pharmacol Ther 2006; 24 (Suppl 4): 278-284
73. Saha A, Hammond CE, Gooz M, Smolka AJ. IL-1beta modulation of H, K-ATPase alpha-subunit gene transcription in Helicobacter pylori infection. Am J Physiol Gastrointest Liver Physiol 2007; 292: G1055-G1061 [PMID: 17204545]
74. Fossmark R, Johnsen G, Johanessen E, Waldum HL. Rebound acid hypersecretion after long-term inhibition of gastric acid secretion. Aliment Pharmacol Ther 2005; 21: 149-154 [PMID: 15679764 DOI: 10.1111/j.1365-2036.2004.02271.x]
75. Courillon-Mallet A, Launay JM, Roucayrol AM, Callebert J, Emond JP, Tabuteau F, Cattan D. Helicobacter pylori infection: physiopathologic implication of N alpha-methyl histamine. Gastroenterology 1995; 108: 959-966 [PMID: 7698611 DOI: 10.1016/0016-5085(95)90190-6]
76. Zavros Y, Rieder G, Ferguson A, Samuelson LC, Merchant JL. Genetic or chemical hypochlorhydria is associated with inflammation that modulates parietal and G-cell populations in mice. Gastroenterology 2002; 122: 119-133 [PMID: 11781287 DOI: 10.1053/gast.2002.30298]
77. Beales I, Blaser MJ, Srinivasan S, Calam J, Pérez-Pérez GI, Yamada T, Scheiman J, Post L, Del Valle J. Effect of Helicobacter pylori products and recombinant cytokines on gastrin release from cultured canine G cells. Gastroenterology 1997; 113: 465-471 [PMID: 9247465 DOI: 10.1053/gast.1997.v113.pm9247465]
78. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, Fraumeni JF, Rabkin CS. The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer. Nature 2001; 412: 99 [PMID: 11808612 DOI: 10.1038/35083631]
79. Chen J, Liu TH, Ye SF, Gu CF, Chen SP. Gastrin and somatostatin cells in dyspeptic patients with and without duodenal ulcer: a quantitative study based on multiple biopsy specimens. J Gastroenterol Hepatol 1989; 4: 41-47 [PMID: 2577464 DOI: 10.1111/j.1440-1746.1989.tb00805.x]
80. Burkitt MD, Varro A, Pritchard DM. Importance of gastrin in the pathogenesis and treatment of gastric tumors. World J Gastroenterol 2009; 15: 1-16 [PMID: 19115463 DOI: 10.3748/wjg.15.1]
81. Chakravorty M, Datta De D, Choudhury A, Roychoudhury S. IL1B promoter polymorphism regulates the expression of gastric acid stimulating hormone gastrin. Int J Biochem Cell Biol 2009; 41: 1502-1510 [PMID: 19166966 DOI: 10.1016/j.biocel.2008.12.017]
82. Datta De D, Bhattacharjya S, Maitra M, Datta A, Choudhury A, Dhali GK, Roychoudhury S. IL1B induced Smad 7 negatively regulates gastrin expression. PLoS One 2011; 6: e14775 [PMID: 21445336 DOI: 10.1371/journal.pone.0014775]
83. Datta De D, Datta A, Bhattacharjya S, Roychoudhury S. NF-kappaB mediated transcriptional repression of acid modifying hormone gastrin. PLoS One 2013; 8: e73409 [PMID: 24009751 DOI: 10.1371/journal.pone.0073409]
84. Stefani CB, de Oliveira RM, Silveira AA, Ferraz LF, Ribeiro ML, Gambero A, Pedrazzoli Júnior J. Expression of Toll-like receptors in enterocromaffin-like cells and their function in histamine release. Dig Dis Sci 2012; 57: 2270-2277 [PMID: 22618577 DOI: 10.1007/s10620-012-2176-6]